Clinical Trial

A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers.

Name: A Study to Investigate the Safety of Novel Dose Ramp-up Schedule(s) When Initiating Sonrotoclax in Participants Treated for Blood Cancers. — clinical trial record (NCT06697184)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1/2

View on ClinicalTrials.gov →

Summary

The purpose of this study is to establish the safety of novel dosing and ramp-up schedules for sonrotoclax in participants with hematological malignancies.

Trial Details

NCT Number	NCT06697184
Lead Sponsor	BeOne Medicines
Conditions	Chronic Lymphocytic Leukemia, CLL, Mantle Cell Lymphoma, MCL
Enrollment	258 participants
Start Date	2025-01-23
Primary Completion	2029-11-30 (estimated)
Study Completion	2032-11-30 (estimated)
Updated on ClinicalTrials.gov	2026-06-08